
Leaps by Bayer led a round that also featured Amgen Ventures, Intel Capital and Alexandria Ventures Investments, taking the gene therapy technology developer's total funding to $158m.
The VR and AR technology developer, which was spun off by iQiyi, has closed an eight-figure series B round co-led by Yitang Changhou Fund and Fresh Capital.
GV and Sidewalk Infrastructure Partners contributed to a $55m round that will support the recycling robot maker's expansion plans.
The autonomous driving software provider completed a series B round led by BP Ventures that also featured corporate investors Tencent and Halma.
Bristol Myers Squibb participated in a series B round for the oncology drug developer that pushed its overall funding to $168m.
The heart disease therapy developer completed a $12.7m round that included Alfresa, Dai-ichi Life, Sony Innovation Fund and Japan Lifeline.
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Meituan Dianping and New Hope Group have both thrown their backing behind a round topping $100m for production automation robot developer Flexiv.
Legend Star and CMB International are among the participants in the cancer drug developer’s latest round, which was led by Tsing Song Capital.
The SFC-backed vaccine developer has wrapped up its series B-2 round after holding an initial close in early 2019.